Bausch Health
BHC
#4603
Rank
ยฃ1.84 B
Marketcap
ยฃ4.94
Share price
0.75%
Change (1 day)
-8.80%
Change (1 year)
Bausch Health is a Canadian company that researches, develops and produces pharmaceuticals and markets patented drugs, generics and non-prescription drugs in the areas of dermatology and ophthalmology.

EPS for Bausch Health (BHC)

EPS in 2026 (TTM): -ยฃ2.46

According to Bausch Health 's latest financial reports the company's current EPS (TTM) is -ยฃ2.38. In 2025 the company made an earnings per share (EPS) of ยฃ0.31 an increase over its 2024 EPS that were of -ยฃ0.08807.

EPS history for Bausch Health from 2012 to 2026

Annual EPS

Year EPS Change
2026 (TTM)-ยฃ2.46-897.68%
2025ยฃ0.31-450%
2024-ยฃ0.08807-92.59%
2023-ยฃ1.19160.89%
2022-ยฃ0.46-76.64%
2021-ยฃ1.9568.45%
2020-ยฃ1.16-68.91%
2019-ยฃ3.72-57.11%
2018-ยฃ8.68-272.22%
2017ยฃ5.04-199.29%
2016-ยฃ5.08798.7%
2015-ยฃ0.57-128.31%
2014ยฃ2.00-204.62%
2013-ยฃ1.91602.7%
2012-ยฃ0.27

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
OPKO Health
OPK
-ยฃ0.20-91.67%๐Ÿ‡บ๐Ÿ‡ธ USA
Onconova Therapeutics
ONTX
-ยฃ0.70-70.68%๐Ÿ‡บ๐Ÿ‡ธ USA